Toot

Written by Ricardo Segurado on 2025-01-27 at 20:13

@neuralreckoning

In terms of the benefit of the data, and all the hype around the medical advances, not a lot has planned out IMHO.

Rare and monogenic diseases have certainly been mapped, but you can often enough do that without full sequence.

Common and chronic disease (where you can get real bang for your buck in terms of population health) has turned out to largely not be dependent on one or two or even a few genes. Largely as expected, really. Clinical benefit has been slow for all..

=> More informations about this toot | View the thread | More toots from red_concrete@mastodon.social

Mentions

=> View neuralreckoning@neuromatch.social profile

Tags